MedTrace Logo

Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19

NCT04374110 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-05-06

No results posted yet for this study

Summary

Hospitalized patients with COVID-19 will be included in the study in centers around Poland. After the hospitalization, a short questionnaire will be completed, including pre-hospitalization diagnoses, pre-hospitalization medications, clinical status on admission, the course, complication and the duration of hospitalization. The questionnaire will be available in paper form and on-line.

Conditions

Interventions

OTHER

Clinical data

Clinical characteristics from medical records

Sponsors & Collaborators

  • National Institute of Cardiology, Warsaw, Poland

    lead OTHER

Principal Investigators

  • Andrzej Januszewicz, MD, PhD · National Institute of Cardiology

  • Tomasz Hryniewiecki, MD, PhD · National Institute of Cardiology

  • Rafal Dabrowski, MD, PhD · National Institute of Cardiology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-05
Primary Completion
2020-06-24
Completion
2021-08-24

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04374110 on ClinicalTrials.gov